Patients with activated B-cell like diffuse large B-cell lymphoma in high and low infectious disease areas have different inflammatory gene signatures

References

• A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997;89:3909–3918.
   PubMed Web of Science ®Google Scholar
• Alizadeh AA, Eisen MB, Davis RE, . Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503–511.
   PubMed Web of Science ®Google Scholar
• Wright G, Tan B, Rosenwald A, . A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2003;100:9991–9996.
   PubMed Web of Science ®Google Scholar
• Naresh KN, Advani S, Adde M, . Report of an International Network of Cancer Treatment and Research workshop on non-Hodgkin's lymphoma in developing countries. Blood Cells Mol Dis 2004;33:330–337.
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Garcia-Buey L, Arranz R, . The prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Eur J Gastroenterol Hepatol 2004;16:135–138.
   PubMed Web of Science ®Google Scholar
• Wong HH, Wang J. Epstein-Barr virus positive diffuse large B-cell lymphoma of the elderly. Leuk Lymphoma 2009;50:335–340.
   PubMed Web of Science ®Google Scholar
• Morales D, Beltran B, De Mendoza FH, . Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma. Leuk Lymphoma 2010;51:66–72.
   PubMed Web of Science ®Google Scholar
• Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene 2004;23:6524–6534.
   PubMed Web of Science ®Google Scholar
• Mele A, Pulsoni A, Bianco E, . Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 2003;102:996–999.
   PubMed Web of Science ®Google Scholar
• Jarrett RF. Viruses and lymphoma/leukaemia. J Pathol 2006;208: 176–186.
   PubMed Web of Science ®Google Scholar
• Moore PS, Chang Y. Why do viruses cause cancer?Highlights of the first century of human tumour virology. Nat Rev Cancer 2010;10: 878–889.
   Google Scholar
• Zhang JY, Dai M, Wang X, . A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Int J Epidemiol 1998;27:574–578.
   PubMed Web of Science ®Google Scholar
• Smedby KE, Baecklund E, Askling J. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev 2006;15:2069–2077.
   PubMed Web of Science ®Google Scholar
• Ferreri AJ, Dognini GP, Campo E, . Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. Haematologica 2007;92:486–492.
   PubMed Web of Science ®Google Scholar
• Nicolosi Guidicelli S, Lopez-Guillermo A, Falcone U, . Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: a case-control study of the International Extranodal Lymphoma Study Group. Hematol Oncol 2012;30:137–142.
   PubMed Web of Science ®Google Scholar
• Nicolaides C, Fountzilas G, Zoumbos N, . Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study. Oncology 1998;55: 405–415.
   PubMed Web of Science ®Google Scholar
• Tilly H, Dreyling M. Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(Suppl. 5):v172–v174.
   PubMed Web of Science ®Google Scholar
• Hans CP, Weisenburger DD, Greiner TC, . Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103: 275–282.
   PubMed Web of Science ®Google Scholar
• Meyer PN, Fu K, Greiner TC, . Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol 2011;29:200–207.
   PubMed Web of Science ®Google Scholar
• Jacobson TA, Lundahl J, Mellstedt H, . Gene expression analysis using long-term preserved formalin-fixed and paraffin-embedded tissue of non-small cell lung cancer. Int J Oncol 2011;38: 1075–1081.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030–3044.
   PubMed Web of Science ®Google Scholar
• Hofscheier A, Ponciano A, Bonzheim I, . Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population. Mod Pathol 2011;24:1046–1054.
   PubMed Web of Science ®Google Scholar
• Gibson SE, Hsi ED. Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype. Hum Pathol 2009;40:653–661.
   PubMed Web of Science ®Google Scholar
• Hoeller S, Tzankov A, Pileri SA, . Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations. Hum Pathol 2010;41:352–357.
   PubMed Web of Science ®Google Scholar
• Oyama T, Ichimura K, Suzuki R, . Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 2003;27:16–26.
   PubMed Web of Science ®Google Scholar
• Oyama T, Yamamoto K, Asano N, . Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res 2007;13:5124–5132.
   PubMed Web of Science ®Google Scholar
• Park S, Lee J, Ko YH, . The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 2007;110:972–978.
   PubMed Web of Science ®Google Scholar
• Darnell JE Jr. STATs and gene regulation. Science 1997;277: 1630–1635.
   PubMed Web of Science ®Google Scholar
• Heim MH, Moradpour D, Blum HE. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J Virol 1999;73:8469–8475.
   PubMed Web of Science ®Google Scholar
• Koeberlein B, zur Hausen A, Bektas N, . Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver. Virus Res 2010;148:51–59.
   PubMed Web of Science ®Google Scholar
• Weber-Nordt RM, Egen C, Wehinger J, . Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 1996;88:809–816.
   PubMed Web of Science ®Google Scholar
• Yamashita H, Nishio M, Ando Y, . Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer. Endocr Relat Cancer 2006;13:885–893.
   PubMedGoogle Scholar
• Lam LT, Wright G, Davis RE, . Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. Blood 2008;111:3701–3713.
   PubMed Web of Science ®Google Scholar
• Li P, Harris D, Liu Z, . Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells. PLoS One 2010;5:e11859.
   PubMed Web of Science ®Google Scholar
• Bock CT, Toan NL, Koeberlein B, . Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinoma. Intervirology 2008;51: 432–443.
   PubMed Web of Science ®Google Scholar
• Horvath CM. Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein. Eur J Biochem 2004;271:4621–4628.
   PubMedGoogle Scholar
• Ulane CM, Rodriguez JJ, Parisien JP, . STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling. J Virol 2003;77:6385–6393.
   PubMed Web of Science ®Google Scholar
• Sobti RC, Singh N, Hussain S, . Deregulation of STAT-5 isoforms in the development of HPV-mediated cervical carcinogenesis. J Recept Signal Transduct Res 2010;30:178–188.
   PubMed Web of Science ®Google Scholar
• Magrath I, Litvak J. Cancer in developing countries: opportunity and challenge. J Natl Cancer Inst 1993;85:862–874.
   PubMed Web of Science ®Google Scholar
• Blinder V, Fisher SG. The role of environmental factors in the etiology of lymphoma. Cancer Invest 2008;26:306–316.
   PubMed Web of Science ®Google Scholar
• Frederiksen BL, Dalton SO, Osler M, Steding-Jessen M, de Nully Brown P. Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark--a nationwide study. Br J Cancer 2012;106:988–995.
   PubMed Web of Science ®Google Scholar
• Choudhury A, Derkow K, Daneshmanesh AH, . Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells. Br J Haematol 2010;151:327–335.
   PubMed Web of Science ®Google Scholar
• Daneshmanesh AH, Mikaelsson E, Jeddi-Tehrani M, . Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy. Int J Cancer 2008;123:1190–1195.
   PubMed Web of Science ®Google Scholar
• Shabani M, Asgarian-Omran H, Vossough P, . Expression profile of orphan receptor tyrosine kinase (ROR1) and Wilms’ tumor gene 1 (WT1) in different subsets of B-cell acute lymphoblastic leukemia. Leuk Lymphoma 2008;49:1360–1367.
   PubMed Web of Science ®Google Scholar